Pharmacokinetics and Safety Profiles After Administration of DA-5221_01 and Co-administration of 5221_01-R1 and DA-5221_01-R2 in Healthy Adult Volunteers

ConditionHealthy

Trial statusNot yet recruiting

Trial phasePhase 1

Trial typeInterventional

Biological sexAll

Age19+

SponsorDong-A ST Co., Ltd.

About this trial

Pharmacokinetics and Safety Profiles After Administration of DA-5221\_01 and Co-administration of 5221\_01-R1 and DA-5221\_01-R2 in Healthy Adult Volunteers

Eligibility criteria

Qualifiers

Healthy volunteers

BMI between 18 and 30 kg/m2

Body weight: Male≥50kg, Female≥45kg

Subjects who have signed an informed consent themselves after receiving detailed explanation about clinical study

Disqualifiers

Subjects with clinically significant medical history

Subjects with history of drug abuse or addicted

Trial design

Treatments tested in this trial

DA-5221_01
DA-5221_01-R1 + DA-5221_01-R2

Treatment groups

44 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Dong-A ST Co., Ltd.

Lead sponsor

Source ClinicalTrials.gov